Pipeline

显示出强大临床性能和对患者有益的先进药物.

Pipeline
90
+
compounds, 单独或在合作或许可协议下开发的设备或适应症
investment
$7.8
b
R&D投资2023年
Commitment
50
+
项目正处于中期和后期开发阶段
Novel
80
%
在临床开发具有新的作用机制的化合物

Pipeline

2024年5月13日更新

Sort By 
Focus Area
分子/资产阶段
分子/资产类型
设备资产阶段
Device Asset Type
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
Hypothyroidism
N ∕ A
N ∕ A phase2
phase2
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
帕金森病
EU US
EU approved
US
approved
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
发作性偏头痛预防
N ∕ A
N ∕ A phase3
phase3
Essential Tremor
N ∕ A
N ∕ A phase2
phase2
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
血液肿瘤
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
IC BPS
N ∕ A
N ∕ A phase2
phase2
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
Crohn's Disease
US , EU
US , EU approved
approved
Psoriasis
US , EU
US , EU approved
approved
银屑病关节炎
US , EU
US , EU approved
approved
溃疡性结肠炎
N ∕ A
N ∕ A
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
复杂的革兰氏阴性感染
N ∕ A
N ∕ A phase3
phase3
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
系统性红斑狼疮(SLE)
Global
Global phase2
phase2
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
阿尔茨海默病
N ∕ A
N ∕ A phase2
phase2
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
阿尔茨海默病
N ∕ A
N ∕ A phase2
phase2
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
晚期胰腺癌
N ∕ A
N ∕ A phase2
phase2
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
Multiple Myeloma
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
开角型青光眼
N ∕ A
N ∕ A phase2
phase2
眼高血压
N ∕ A
N ∕ A phase2
phase2
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
阿尔茨海默病
N ∕ A
N ∕ A phase2
phase2
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
溃疡性结肠炎
N ∕ A
N ∕ A phase2
phase2
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
系统性红斑狼疮(SLE)
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
IBD
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
湿性黄斑变性(视网膜下)
N ∕ A
N ∕ A phase3
phase3
湿性黄斑变性(脉络膜上)
N ∕ A
N ∕ A phase2
phase2
糖尿病视网膜病变(脉络膜上病变)
N ∕ A
N ∕ A phase2
phase2
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
肌萎缩侧索硬化(ALS)
N ∕ A
N ∕ A phase2
phase2
消失性白质病(VWM)
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
非小细胞肺癌
N ∕ A
N ∕ A phase3
phase3
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
血液肿瘤
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
慢性偏头痛预防
US , EU
US , EU approved
approved
发作性偏头痛预防
US , EU
US , EU approved
approved
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
Glabellar Lines
N ∕ A
N ∕ A phase3
phase3
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
阔肌突出
N ∕ A
N ∕ A
咬肌突出
CN N ∕ A
CN
N ∕ A phase3
phase3
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
Atopic Dermatitis
N ∕ A
N ∕ A phase2
phase2
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
复发性∕难治性弥漫性大b细胞淋巴瘤
US , EU
US , EU approved
approved
复发性滤泡性淋巴瘤
N ∕ A
N ∕ A
一线滤泡性淋巴瘤
N ∕ A
N ∕ A phase3
phase3
一线大b细胞淋巴瘤
US , EU
US , EU phase3
phase3
b细胞非霍奇金淋巴瘤
N ∕ A
N ∕ A phase2
phase2
复发性慢性淋巴细胞白血病
N ∕ A
N ∕ A phase1
phase1
里希特氏综合征
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
Spinal Cord Injury
N ∕ A
N ∕ A phase2
phase2
急性缺血性中风
N ∕ A
N ∕ A phase2
phase2
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
Bipolar Depression
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
Alopecia Areata
N ∕ A
N ∕ A phase3
phase3
强直性脊柱炎
US , EU
US , EU approved
approved
Atopic Dermatitis
US , EU
US , EU approved
approved
Axial SpA
US , EU
US , EU approved
approved
Crohn's Disease
US , EU
US , EU approved
approved
巨细胞动脉炎
US , EU
US , EU phase3
phase3
位患化脓性汗腺炎
N ∕ A
N ∕ A phase3
phase3
银屑病关节炎
US , EU
US , EU approved
approved
类风湿性关节炎
US , EU
US , EU approved
approved
系统性红斑狼疮(SLE)
N ∕ A
N ∕ A phase3
phase3
Takayasu Arteritis
JA
JA phase3
phase3
溃疡性结肠炎
US , EU
US , EU approved
approved
Vitiligo
N ∕ A
N ∕ A phase3
phase3
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
Colorectal Cancer
N ∕ A
N ∕ A phase2
phase2
Solid Tumors
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
HIV
N ∕ A
N ∕ A phase2
phase2
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
铂耐药卵巢癌
N ∕ A
N ∕ A approved
approved
铂敏感卵巢癌
N ∕ A
N ∕ A phase3
phase3
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
Solid Tumors
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
Liver
N ∕ A
N ∕ A phase2
phase2
Solid Tumors
N ∕ A
N ∕ A phase1
phase1
非小细胞肺癌
N ∕ A
N ∕ A phase2
phase2
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
血液肿瘤
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
位患化脓性汗腺炎
N ∕ A
N ∕ A phase2
phase2
溃疡性结肠炎
N ∕ A
N ∕ A phase2
phase2
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
小细胞肺癌
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
Solid Tumors
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
Solid Tumors
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
Solid Tumors
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
Solid Tumors
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
Ovarian Cancer
N ∕ A
N ∕ A phase1
phase1
子宫内膜癌
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
mCRPC
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
BPDCN
N ∕ A
N ∕ A phase2
phase2
急性髓性白血病
N ∕ A
N ∕ A phase2
phase2
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
急性髓性白血病
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
滤泡淋巴瘤
US , EU
US , EU phase3
phase3
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
血液肿瘤
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
复发/难治性多发性骨髓瘤
N ∕ A
N ∕ A phase1
phase1
潜在的迹象
Region
Phase 1 Phase 2 Phase 3 Status
Status
急性淋巴细胞白血病
N ∕ A
N ∕ A phase1
phase1
急性髓性白血病
US , EU
US , EU approved
approved
急性髓系白血病移植后
N ∕ A
N ∕ A phase3
phase3
慢性淋巴细胞白血病伴17p缺失
US , EU
US , EU approved
approved
一线慢性淋巴细胞白血病
US , EU
US , EU approved
approved
骨髓增生异常综合征
US , EU
US , EU phase3
phase3
复发性慢性淋巴细胞白血病
US , EU
US , EU approved
approved
潜在的迹象
Region
Feasibility Development Confirmation Status
Status
Atrophic Scars
N A
N A confirmation
confirmation
潜在的迹象
Region
Feasibility Development Confirmation Status
Status
Facial Volume
EU N A
EU approved
N A development
approved
development
潜在的迹象
Region
Feasibility Development Confirmation Status
Status
眼眶下的挖空
US
US approved
approved
潜在的迹象
Region
Feasibility Development Confirmation Status
Status
Cellulite
N A
N A development
development
潜在的迹象
Region
Feasibility Development Confirmation Status
Status
细线还原
US , EU , JA
US , EU , JA approved
approved
颈线缩小
N A
N A confirmation
confirmation
潜在的迹象
Region
Feasibility Development Confirmation Status
Status
Jawline Definition
US
US approved
approved
潜在的迹象
Region
Feasibility Development Confirmation Status
Status
Facial Volume
N A
N A confirmation
confirmation
潜在的迹象
Region
Feasibility Development Confirmation Status
Status
寺庙增大
US
US approved
approved
No Results Found 更改过滤或搜索条件.